Bluebird


Bluebird Bio Inc Gains a New Bull; John Newman Drawn to bb2121’s Long-Term Potential

Canaccord’s John Newman sees 24% upside potential for BLUE shares.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts